Symptom-based liver enzyme and triglyceride testing is proposed for isotretinoin patients without risk factors to reduce ...

FDA approved veligrotug-vvze for TED regardless of activity or duration, using a 12-week course of five IV infusions administered every three weeks. Pivotal THRIVE/THRIVE-2 trials met primary and all ...

CAA 2026 mandates rebate pass-through and at least twice-yearly reporting on spread pricing, acquisition costs, and rebate amounts. Enforcement provisions include $10,000-per-day penalties for ...

IQVIA projects 118 U.S. biologics losing exclusivity by 2034 (~$234B opportunity), but only 12 had biosimilars in development as of Sept 2024, leaving most molecules uncontested. FDA draft guidance ...

Enhanced premium tax credits doubled ACA enrollment to >24 million, but their end in 2025 plus premium increases is associated with 17%–26% projected enrollment declines and rising premium nonpayment.

Benchmarking that prioritizes exam-style final answers misses core clinical work: uncertainty management, evolving information, and stepwise reasoning across the diagnostic workflow. Multi-model ...

Marc Elia of Invyvid explains the difference between vaccines and monoclonal antibodies. Many people overlook the fundamental difference between vaccines and monoclonal antibodies, but the distinction ...

The CEOs of CVS Health and UnitedHealth Group praised pharmacy benefit managers and promised transparency during investor calls. A critic of the “big 3” dismissed the statements as posturing. At a ...

Survey findings show persistent high insulin out-of-pocket spending, with 72% exceeding $35 per month and nearly 40% exceeding $150 per month. Financial strain from insulin costs is linked to care ...

Improving outcomes in chronic conditions will require eliminating friction and creating a connected foundation that supports people continuously.